Voorhees Seth Van

Chief Financial Officer, AMERICAN PACIFIC CORP.

Companies

NRX Pharmaceuticals, Inc.Chief financial officer Jun 29, 2022 to Dec 19, 2022¹
PDS Biotechnology CorpChief financial officer Jan 6, 2021 to Jun 17, 2021²
RESEARCH FRONTIERS INCChief financial officer Jan 10, 2011 to Feb 24, 2020³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

NRX Pharmaceuticals, Inc. NRXP62,714 shares⁴$168.4K at $2.69Dec 16, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 16, 2022Bought 30,000 shares at $1.10 of NRX Pharmaceuticals, Inc.⁴
Nov 25, 2022Bought 7,021 shares at $1.11 of NRX Pharmaceuticals, Inc.⁵
Nov 25, 2022Bought 7,021 shares at $1.11 of NRX Pharmaceuticals, Inc.⁶
Nov 25, 2022Bought 600 shares at $1.10 of NRX Pharmaceuticals, Inc.⁵
Nov 25, 2022Bought 600 shares at $1.10 of NRX Pharmaceuticals, Inc.⁶
Nov 25, 2022Bought 8,716 shares at $1.12 of NRX Pharmaceuticals, Inc.⁵
Nov 25, 2022Bought 8,716 shares at $1.12 of NRX Pharmaceuticals, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNRX Pharmaceuticals, Inc., Chief financial officer
2
SEC EDGARPDS Biotechnology Corp, Chief financial officer
3
SEC EDGARRESEARCH FRONTIERS INC, Chief financial officer
4
SEC EDGARNRX Pharmaceuticals, Inc. shares after the filing of Dec 16, 2022
5
SEC EDGARForm 4 filed Dec 19, 2022
6
SEC EDGARForm 4 filed Nov 28, 2022